Complement activation is associated with a variety of immunologically-mediated renal diseases. Proximal tubular epithelial cells in situ constitutively express messenger RNA for C4 of the complement system. These same epithelial cells in culture have been reported to contain message for C3 and to secrete this protein when stimulated by IL-2. The present study compared the in situ localization of C3 and C4 message in parallel in a variety of renal biopsy and nephrectomy specimens. All adequate tissue samples (a = 23) had C4 mRNA throughout in the cortical tubular epithelium. Although C3 message was also expressed in tubular epithelial cells, there was much greater variation in its distribution. mRNA for C3 was not detected in histologically normal specimens (a = 4) either by in situ or Northern hybridization. Focal C3 message correlated with focal histologic abnormalities (e.g., focal glomerulosclerosis), while more generalized C3 signal occurred in specimens with more diffuse inflammatory processes (e.g, SLE). Infiltrating inflammatory cells and cells of the glomeruli were uniformly negative for C3 (and C4) message. Tubular C3 and C4 mRNA appeared to be translated, since selected specimens showed cytoplasmic staining by monoclonal antibodies to C3c and C4c. These observations are consistent with the hypothesis that local production of inflammatory mediators could induce C3 synthesis in the renal interstitium, with the possibility that subsequent complement activation could enhance the pathogenic process. (J.
Introduction
Activation of the complement system generates a highly regulated cascade of inflammatory mediators that promote host defense from foreign organisms. Unfortunately, these same mediators may also contribute to host tissue injury. Complement activation is associated with immunologically mediated renal diseases such as SLE, membranoproliferative glomerulonephri-tis (MPGN)', and acute poststreptococcal glomerulonephritis.
The evidence for this includes systemic complement component depletion (1) , the presence of circulating complement activation products (2) , and the deposition of complement components with other immune reactants in the kidney (3) .
A number of biologically active proteins central to the inflammatory response can be synthesized at their site of action. Tissue kallikrein and histamine, for example, are released in the lung after allergen challenge and play an important role in asthma (4) . Synovial tissues have also been shown to release cytokines and other peptides during active arthropathies (5) . Although the liver is the presumed source of most circulating complement components in humans, the possibility exists that local synthesis ofthese proteins plays a role in some inflammatory conditions. In at least one animal model of complementmediated disease, the MRL lpr/lpr mouse, progressive injury is associated with upregulated extrahepatic transcription of the genes for components C2, C3, C4, and B (6) . The apparent tissue-specific nature ofthis regulation further supports the possibility ofa local role and the potential for its specific pharmacologic modulation.
In a previous study (7) , we demonstrated the constitutive expression of C4 mRNA by human renal tubular epithelial cells in situ. In the current study, we examine the localization of C3 message in the human kidney.
Methods
Tissues. Fresh human kidney tissue was obtained at the time of nephrectomy or open or percutaneous renal biopsy, snap frozen in liquid nitrogen, and stored at -70'C. Non-tumor-containing areas of kidneys removed because of Wilms' tumor, as well as renal biopsy specimens which were obtained because ofminimal asymptomatic urinary abnormalities, were considered "normal" tissues on the basis of negative findings by light, immunofluorescence, and electron microscopy.
Nucleic acid probes. The plasmid pHLC3. 1 1 containing a 4.3-kb C3 cDNA insert was obtained from the American Type Culture Collection (Rockville, MD) (8) . A 320-bp fragment containing exons 28 and 29 was amplified by the polymerase chain reaction in a thermal cycler (Perkin-Elmer Cetus Instruments, Norwalk, CT) to contain terminal BamHI and KpnI restriction sites, and subcloned into pBluescript II (Stratagene Inc., La Jolla, CA). Transcription in the presence of 35S-UTP (Amersham Corp., Arlington Heights, IL), using T3 or T7 RNA polymerase, yielded single-stranded, radiolabeled, antisense or sense probes, respectively, for C3 message. RNA probes for C4 were generated as described previously (7) . Radiolabeled probes were gel purified or passed over columns (Quick Spin; Boehringer-Mannheim Corp., Indianapolis, IN) to remove unincorporated nucleotide before in situ hybridization.
Northern analyses. Total RNA was prepared from frozen tissue by guanidinium isothiocyanate, acid phenol, and chloroform extractions (9) . The RNA was separated by electrophoresis in agarose, transferred to nitrocellulose, and hybridized with 32P-labeled DNA probes for C4 and actin as previously described (7) . In addition, a 1.8-kb fragment obtained by Clal and SalI digestion ofpHLC3. 1 1 was used to probe for C3 message.
In situ hybridization method. Cryostat sections ( 12 abnormality were positive for C3 mRNA by in situ hybridization. In general, the signal in positive cases was restricted to the proximal tubular epithelium. This signal was diffuse in some generalized inflammatory processes such as SLE (Fig. 2, A-D) , but was usually focal in processes with a more limited distribution of histologic abnormality (Fig. 2, E and F) . There was a complete lack ofglomerular or vessel-wall signal. Occasionally, a tubularized crescent (composed of epithelial cells) showed C3 message (Fig. 2 B) .
By sequentially examining identical sections with dark field and bright field illumination, it was possible to correlate the distribution of C3 message to histology with considerable precision. Although the tubules that were adjacent to inflammatory infiltrates were generally positive for C3 message, the signal was clearly in the epithelium and not in the infiltrating cells (Fig. 2, G and H) . C4 mRNA expression was always generalized in cortical epithelial cells, in a pattern clearly different from that of C3 (Fig. 3, A-F) (7) .
Immunohistochemistry. A representative renal specimen (case 91-540, Table I ), which had a diffuse distribution of C3 and C4 mRNA in renal tubular epithelial cells by in situ hybridization, also had specific staining for C3 and C4 protein in the cytoplasm of these same cells by immunohistochemistry (Fig.  4) . Monoclonal anti-C3c and anti-C4c were used, since these antigenic determinants should be available on intact C3 and C4. Monoclonal anti-C3d and anti-C4d staining was used for comparison, since these determinants remain on extracellular deposits of these components after complement activation. With anti-C3c and anti-C4c (Fig. 4, E-H) , only tubules were stained, while glomerular and infiltrating cells were generally negative. In contrast, glomeruli, tubules, and blood vessels were stained by anti-C3d and anti-C4d (Fig. 4, I and J). Previous studies (7) using polyclonal antisera produced results similar to those with monoclonal anti-C4d and failed to detect cytoplasmic C4 protein in the renal tubular epithelium or in hepatocytes of the liver (a known source of C4). Examination of liver sections with monoclonal anti-C4d and anti-C3d also showed no staining ofhepatocytes while the cytoplasm ofthese cells was clearly stained by anti-C4c and anti-C3c (Fig. 4, A-D) . Thus, for both C3 and C4, mRNA and protein seem to colocalize as long as antisera to determinants exposed on the intact complement components are used.
Discussion
For most immune-mediated glomerulonephritides, complement components are present with other immune reactants in the glomerular lesions (3) . In some cases, these components may represent complexes formed in the circulation and trapped in the kidney; complement is probably deposited on these complexes in the circulation. Alternatively, complexes may form in the glomerulus and react with available complement locally. In either scenario, the deposited complement has been presumed to derive from the circulation, after synthesis in the liver.
A number of extrahepatic tissues and cell lines have been shown to syntheeize specific complement components, both in vivo (7) and in vitro (10) (11) (12) a-. .A tempting to speculate that such local synthesis could be relevant to renal inflammatory disease, there have been no data to support such a possibility until recently. Studies in our laboratory have shown that mRNA for C4 can be detected in samples ofboth normal and diseased human kidneys. By in situ hybridization, we were able to localize this message to the proximal tubular epithelium. The signal was not identified in glomeruli, and was uniform in intensity and distribution throughout the samples studied (Fig. 2, B-D in reference 7) . These findings did not support a contribution of local C4 synthesis to renal disease; a role in local immunity could not be excluded ( 13) .
We next examined C3 gene expression, in light of the central place this protein holds in the inflammatory cascade. Our preliminary studies by Northern analysis suggested that mRNA for this component was not present in healthy kidneys, but was demonstrable in organs affected by a variety ofnephritides. Subsequent investigations by Brooimans et al demonstrated both C3 message and functionally active C3 protein in cultured human proximal tubular epithelial cells. C3 synthesis in this system could be upregulated by IL-2. These workers speculated that such regulated local synthesis could be important in immune complex disease, but did not study any cells of glomerular origin ( 14) .
Our data confirm in vitro studies that suggest human kidney tissue can be a source ofC3. The absence ofC3 message in normal kidney tissue, by both Northern analysis and in situ hybridization, suggests that this component is differentially regulated in comparison to C4. In addition, immunohistochemical examination of representative tissues confirms that the C3 and C4 message detected in situ is translated into protein.
Not only is C3 expression limited to abnormal kidneys, its cellular localization is usually focal and restricted to areas of inflammation. As is the case for C4, tubular epithelial cells are the source ofthis C3 mRNA. There is no evidence ofglomerular message. In addition, there is no evidence of C3 mRNA in vascular endothelium or in the infiltrating inflammatory cells themselves.
These data, then, do not support the hypothesis ofa role for locally synthesized C3 in direct glomerular injury. They do, however, raise the possibility that such local synthesis contributes to interstitial renal disease, including the interstitial component of advanced glomerulonephritis. A variety of glomerulonephritides, especially those with a proliferative component, are associated with a marked peritubular inflammatory reaction ( 15 ) . The glomerular mesangium synthesizes a number of growth factors and cytokines, both in vivo and in vitro ( 16, 17) . At least one of these, IL-6, apparently can gain access to the glomerular circulation from the mesangium ( 17) . In vitro studies have shown that cultured renal tubular epithelial cells can respond to cytokine stimulation with upregulation of C3 synthesis ( 14) .
A reasonable hypothesis, consistent with our data, is that a glomerular inflammatory reaction induces C3 gene expression in the corresponding tubules. For example, Fig. 2 , E and F illustrate the proximal tubule derived from an injured glomerulus that is both positive for C3 message and shows peritubular inflammation. In the ammonia-rich peritubular interstitium, locally synthesized C3 could be amidated to NH3 *C3, as recently proposed by Nath and Hostetter (18) . Fluid phase NH3 * C3 has stimulatory effects on polymorphonuclear leukocytes and monocytes that are greater than that of C3a ( 19). Furthermore, NH3. C3 can cleave C3 to C3b, which is then available for deposition on surfaces. This cleavage also releases C3a, another potent inflammatory mediator.
If such a mechanism were operative, then specific antagonism of tubular C3 gene expression could play an important role in the treatment of some acute and chronic glomerulonephritides. Such an approach will require understanding of the elements responsible for this tissue-regulated gene expression. 
